IMTRADE DICLOFOP-METHYL 375 SELECTIVE HERBICIDE Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

imtrade diclofop-methyl 375 selective herbicide

imtrade australia pty ltd - diclofop-methyl; liquid hydrocarbon - emulsifiable concentrate - diclofop-methyl phenoxy acids-propionics active 375.0 g/l; liquid hydrocarbon solvent other 531.4 g/l - herbicide - barley | buffalo grass lawn or turf | canola oilseed crop | carpet grass lawn or turf | cereal rye | common couch lawn or turf | - annual or wimmera ryegrass | common barb grass | crowsfoot grass | wild or black oat | crab grass | rigid ryegrass | spring oat | wimmera ryegrass

IMTRADE CYCLONE 330 EC HERBICIDE Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

imtrade cyclone 330 ec herbicide

imtrade australia pty ltd - pendimethalin; liquid hydrocarbon - emulsifiable concentrate - pendimethalin anilide/aniline-dinitro active 330.0 g/l; liquid hydrocarbon solvent other 568.0 g/l - herbicide - avocado | bahia grass | banana | barley - prior to sowing | bent grass | broccoli transplant - prior to sowing | buffalo grass l - annual nettles - supression | annual nettles - urtica spp. | annual or wimmera ryegrass | annual sedge(cyperus spp.) - suppression | asthma plant | awnless barnyard grass | barnyard or water grass | bathurst burr | blackberry nightshade | blackberry nightshade - suppression | bladder ketmia | blue billygoat weed | button grass | caltrop or yellow vine | caltrop or yellow vine - suppression | capeweed - suppression | chickweed | cobbler's pegs | common heliotrope | common sowthistle - suppression | common verbena - supression | crested goosefoot | crowsfoot grass | curious weed | deadnettle | dock - seedling | dwarf amaranth or boggabri weed | early spring grass | erodium spp. - suppression | fat hen | fumitory | fumitory - suppression | green amaranth | green fat hen | green summer grass - b. subquadripara | guinea grass - see label for cultivars | indian hedge mustard | indian hedge mustard - suppression | lesser swinecress or bittercress | liverseed or urochloa grass | mintweed | mintweed - suppression | mo

IMTRADE MCPA LVE 500 EC HERBICIDE Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

imtrade mcpa lve 500 ec herbicide

imtrade australia pty ltd - mcpa present as the iso octyl ester; liquid hydrocarbon - emulsifiable concentrate - mcpa present as the iso octyl ester phenoxy acids-mcpa-ester active 500.0 g/l; liquid hydrocarbon solvent other 150.0 g/l - herbicide - barley | cereal rye | grass pasture - established (see label) | grass seed crop - establised (see label) | oats | triticale | wh - bathurst burr | capeweed | charlock | dandelion - taraxacum officinale | fat hen | fumitory | hedge or wild mustard | lincoln weed, sand rocket or mustard | london rocket | noogoora burr | paterson's curse | saffron thistle | scotch thistle | skeleton weed | slender, shore or sheep thistle | spear or black thistle | stinkwort | turnip weed | variegated thistle | volunteer canola or rapeseed | volunteer safflower | volunteer sunflower | wild radish or radish weed | wild sage | wild turnip | blessed thistle | brassica campestris | brassica kaber | brassica rapa ssp. sylvestris | brassica rapa var. sylvestris | brassica sinapistrum | bull thistle | cabbage thistle | carduus marianus | cockleburr | common dandelion | cotton thistle | crambling mustard | echium lycopsis | echium spp. | english dandelion | european dandelion | false star thistle | giant mustard | hedge mustard | heraldic thistle | holy thistle | jointed charlock | lady's thistle | milk thistle | pink weed | purple bugloss | purple viper's bugloss |

IMTRADE CYPERSHIELD 200 INSECTICIDE Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

imtrade cypershield 200 insecticide

imtrade australia pty ltd - cypermethrin; liquid hydrocarbon - emulsifiable concentrate - cypermethrin pyrethroid active 200.0 g/l; liquid hydrocarbon solvent other 645.0 g/l - insecticide - barley | broccoli | brussels sprouts | cabbage | canola | cauliflower | cereal crop - prior to sowing | chickpea | chinese cabba - armyworm - mythimna spp. | armyworm - persectania spp. | cabbage moth | cabbage white butterfly | cluster caterpillar | common armyworm - mythimna convecta | corn earworm | cotton budworm or bollworm | cotton looper | cutworm - agrotis spp. | grey cluster bug | helicoverpa spp. | native budworm or bollworm | pea weevil | plague thrips | redlegged earth mite | rough bollworm | rutherglen bug | sorghum midge | southern or barley armyworm | soybean looper | tobacco budworm | tomato grub | webworm | barley armyworm | barley grub | corn earworm | cotton bollworm | diachrysia orichalceaa | diamondback moth | heliothis | leucania convecta | native bollworm | native budworm | red legged earth mite | southern armyworm | tobacco budworm | tomato grub

IMTRADE HALOXYFOP 900 EC HERBICIDE Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

imtrade haloxyfop 900 ec herbicide

imtrade australia pty ltd - haloxyfop-p present as the haloxyfop-p-methyl - emulsifiable concentrate - haloxyfop-p present as the haloxyfop-p-methyl phenoxy acids-propionics active 900.0 g/l - herbicide

Imtrade Guerrilla Herbicide Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

imtrade guerrilla herbicide

imtrade australia pty ltd - paraquat present as paraquat dichloride; amitrole - soluble concentrate - paraquat present as paraquat dichloride pyridine-bipyridyl active 300.0 g/l; amitrole triazole active 12.0 g/l - herbicide

Pfizer (Australia) DAUNORUBICIN (as hydrochloride) 20mg/10mL injection vial Australia - engelsk - Department of Health (Therapeutic Goods Administration)

pfizer (australia) daunorubicin (as hydrochloride) 20mg/10ml injection vial

pfizer australia pty ltd - daunorubicin, quantity: 20 mg - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - indications as at 22 november 2004 : daunorubicin injection is indicated for the treatment of the following: acute lymphocytic (lymphoblastic) leukaemia: daunorubicin is usually reserved for use in cases shown to be resistant to other drugs. however, combined treatment with daunorubicin, vincristine and a steroid has been used in the early stages of this disease. acute myeloblastic leukaemia: daunorubicin has been used in all stages, alone or in combination with other cytotoxic agents (e.g. cytarabine). disseminated solid tumours: daunorubicin has been investigated for use in these tumours and found to be effective in some cases of disseminated neuroblastoma and rhabdomyosarcoma.

LENALICIP lenalidomide 25 mg capsule blister pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

lenalicip lenalidomide 25 mg capsule blister pack

cipla australia pty ltd - lenalidomide, quantity: 25 mg - capsule - excipient ingredients: lactose; microcrystalline cellulose; croscarmellose sodium; magnesium stearate; titanium dioxide; sorbitan monolaurate; potable water; gelatin; sodium lauryl sulfate; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; shellac glaze-45% (20% esterified) in ethanol - multiple myeloma (mm) lenalidomide is indicated for the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation. lenalidomide is indicated for the maintenance treatment of patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide in combination with dexamethasone is indicated for the treatment of multiple myeloma patients whose disease has progressed after one therapy.,myelodysplastic syndromes (mds) lenalidomide is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.

LENALICIP lenalidomide 20 mg capsule blister pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

lenalicip lenalidomide 20 mg capsule blister pack

cipla australia pty ltd - lenalidomide, quantity: 20 mg - capsule - excipient ingredients: lactose; microcrystalline cellulose; croscarmellose sodium; magnesium stearate; titanium dioxide; sorbitan monolaurate; potable water; gelatin; sodium lauryl sulfate; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; shellac glaze-45% (20% esterified) in ethanol - multiple myeloma (mm) lenalidomide is indicated for the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation. lenalidomide is indicated for the maintenance treatment of patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide in combination with dexamethasone is indicated for the treatment of multiple myeloma patients whose disease has progressed after one therapy.,myelodysplastic syndromes (mds) lenalidomide is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.

LENALICIP lenalidomide 15 mg capsule blister pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

lenalicip lenalidomide 15 mg capsule blister pack

cipla australia pty ltd - lenalidomide, quantity: 15 mg - capsule - excipient ingredients: lactose; microcrystalline cellulose; croscarmellose sodium; magnesium stearate; titanium dioxide; sorbitan monolaurate; potable water; gelatin; sodium lauryl sulfate; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; shellac glaze-45% (20% esterified) in ethanol - multiple myeloma (mm) lenalidomide is indicated for the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation. lenalidomide is indicated for the maintenance treatment of patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide in combination with dexamethasone is indicated for the treatment of multiple myeloma patients whose disease has progressed after one therapy.,myelodysplastic syndromes (mds) lenalidomide is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.